June 12, 2009 (FinancialWire) — The Medicis (NYSE: MRX) board of directors declared a quarter-end cash dividend of $0.04 per issued and outstanding share of its common stock payable on July 31, 2009, to stockholders of record at the close of business on July 1, 2009.

Medicis is an independent specialty pharmaceutical company focusing primarily on the treatment of dermatological and aesthetic conditions.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.